Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.

Three typical absorption enhancers, i.e., sodium caprate (Cap-Na), sodium deoxycholate (Deo-Na), and dipotassium glycyrrhizinate (Grz-K), were compared in terms of their permeability-enhancing effects on hydrophilic and hydrophobic model compounds in Caco-2 cell monolayers. The transepithelial electrical resistance (TEER) of the monolayers was reduced concentration-dependently by treatment with Cap-Na and Deo-Na, while treatment with Grz-K increased the TEER. Two patterns of TEER reduction were observed: one pattern indicated that Cap-Na had a rapid reducing effect, and another indicated that Deo-Na had a delayed reducing effect. These reductions in the TEER were accompanied by the increased transepithelial transport of two hydrophilic model compounds, sodium fluorescein (Flu-Na; MW = 376, log P = -1.52) and fluorescein isothiocyanate-dextran 4000 (FD-4; MW = 4400, log P = -2.0), and one hydrophobic model compound, rhodamine 123 hydrate (Rh123; MW = 381, log P = 1.13). The transport-enhancing effects of Cap-Na and Deo-Na on these model compounds decreased in the following order: FD-4 > Rh123 > Flu-Na, while Grz-K was found to have no effect on the transport of any of these model compounds. Confocal laser scanning microscopy (CLSM) of Caco-2 cell monolayers revealed that Cap-Na and Deo-Na enhanced the transepithelial transport of the hydrophilic model compounds via the paracellular route and that of the hydrophobic model compound via both paracellular and transcellular routes. Semiquantitative visual information obtained from CLSM images reflected the results of the transport experiment.

[1]  P. Artursson,et al.  Transport of celiprolol across human intestinal epithelial (Caco‐2) cells: mediation of secretion by multiple transporters including P‐glycoprotein , 1993, British journal of pharmacology.

[2]  M Mishima,et al.  Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I. , 1989, Journal of pharmacobio-dynamics.

[3]  M. Pinto,et al.  Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture , 1983 .

[4]  U. Kompella,et al.  Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. , 1991, Critical reviews in therapeutic drug carrier systems.

[5]  M. Spitaler,et al.  Detection of activity of P‐glycoprotein in human tumour samples using rhodamine 123 , 1992, British journal of haematology.

[6]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.

[7]  D. Breimer,et al.  Intestinal drug absorption enhancement: an overview. , 1989, Pharmacology & therapeutics.

[8]  Z. Gatmaitan,et al.  The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. , 1992, Gastroenterology.

[9]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[10]  D. Breimer,et al.  Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers. , 1994, Biochemical pharmacology.

[11]  R. T. Jackson,et al.  Effect of bile salts on nasal permeability in vitro. , 1987, Journal of pharmaceutical sciences.